Company
Cylene Pharmaceuticals
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Cylene Pharmaceuticals, Inc. was founded to develop targeted small-molecule drugs to treat life-threatening cancers. The company’s lead drug was CX-3543, which was developed through Phase II clinical trials.
Loading relationship preview